Modulation of insulin dose titration using a hypoglycaemia-sensitive algorithm: Insulin glargine versus neutral protamine Hagedorn insulin in insulin-naïve people with type 2 diabetes

Diabetes, Obesity and Metabolism

Volumn 17, Issue 1, 2015, Pages 15-22

  Home, P D ^a   Bolli, G B ^b   Mathieu, C ^c   Deerochanawong, C ^d   Landgraf, W ^e   Candelas, C ^f   Pilorget, V ^f   Dain, M P ^f   Riddle, M C ^g  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF PERUGIA   (Italy)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d RANGSIT UNIVERSITY   (Thailand)

^e Process Development Biotechnology   (Germany)

^f SANOFI   (France)

^g OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Hypoglycaemia sensitive algorithm; Insulin glargine; NPH insulin

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; GLIMEPIRIDE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN; INSULIN GLARGINE; ISOPHANE INSULIN; METFORMIN; REPAGLINIDE; SULFONYLUREA; ANTIDIABETIC AGENT; HEMOGLOBIN A1C PROTEIN, HUMAN; LONG ACTING INSULIN; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ALGORITHM; ARTICLE; ASIA; BLEEDING; BODY MASS; BRAIN HEMORRHAGE; CONTROLLED STUDY; DRUG DOSE TITRATION; DRUG WITHDRAWAL; EUROPE; EVENING DOSAGE; FEMALE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; HYPOGLYCEMIA SENSITIVE ALGORITHM; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; METASTATIC RENAL CANCER; MIDDLE EAST; NOCTURNAL HYPOGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN STUDY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SOUTH AMERICA; SUBARACHNOID HEMORRHAGE; THORACIC HEMORRHAGE; ADVERSE EFFECTS; BLOOD; BLOOD GLUCOSE MONITORING; CHEMICALLY INDUCED; CIRCADIAN RHYTHM; CLINICAL TRIAL; COMPARATIVE STUDY; DIABETES MELLITUS, TYPE 2; DOSE CALCULATION; DRUG COMBINATION; DRUG RESISTANCE; HYPERGLYCEMIA; HYPOGLYCEMIA; MIDDLE AGED; MULTICENTER STUDY; SOUTH AFRICA;

AGED; ASIA; BLOOD GLUCOSE SELF-MONITORING; CIRCADIAN RHYTHM; DIABETES MELLITUS, TYPE 2; DRUG DOSAGE CALCULATIONS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; EUROPE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN GLARGINE; INSULIN, ISOPHANE; INSULIN, LONG-ACTING; MALE; METFORMIN; MIDDLE AGED; MIDDLE EAST; SOUTH AFRICA; SULFONYLUREA COMPOUNDS;

EID: 84919634964     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.12329     Document Type: Article

References (11)

1. International Diabetes Federation. IDF Clinical Guidelines Task Force. Global guideline for type 2 diabetes. International Diabetes Federation Web site. 2012. Available from URL: https://www.aace.com/files/dm-guidelines-ccp.pdf. Accessed 3 April 2013.
2. Inzucchi SE, Bergenstal RM, Buse JB et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012; 35: 1364-1379.
3. NICE. Blood-glucose-lowering therapy for type 2 diabetes. Available from URL: http://pathways.nice.org.uk/pathways/diabetes/blood-glucose-lowering-therapy-for-type-2-diabetes. Accessed 6 December 2013.
4. Rodbard HW, Blonde L, Braithwaite SS et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007; 13(Suppl. 1): 1-68.
5. Hermansen K, Davies M, Derezinski T, Martinez RG, Clauson P, Home P. A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes. Diabetes Care 2006; 29: 1269-1274.
6. Riddle MC, Rosenstock J, Gerich J. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 2003; 26: 3080-3086.
7. Home PD, Fritsche A, Schinzel S, Massi-Benedetti M. Meta-analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin glargine. Diabetes Obes Metab 2010; 12: 772-779.
8. Little S, Shaw J, Home P. Hypoglycemia rates with basal insulin analogs. Diabetes Technol Ther 2011; 13(Suppl. 1): S53-64.
9. Mullins P, Sharplin P, Yki-Jarvinen H, Riddle MC, Haring HU. Negative binomial meta-regression analysis of combined glycosylated hemoglobin and hypoglycemia outcomes across eleven Phase III and IV studies of insulin glargine compared with neutral protamine Hagedorn insulin in type 1 and type 2 diabetes mellitus. Clin Ther 2007; 29: 1607-1619.
10. Bradley C. Diabetes Treatment Satisfaction Questionnaire (DTSQ). In: Bradley C, ed. Handbook of Psychology and Diabetes. Chur, Switzerland: Harwood Academic Publishers, 1994; 111-133.
11. Arnolds S, Heise T, Flacke F, Sieber J. Common standards of basal insulin titration in T2DM. J Diabetes Sci Technol 2013; 7: 771-788.